The latest issue of GEN summarizes the VC activity in the biotech space for 2017 so far. There were 205 deals through the end of Q2 in which a total of $4.697B was raised. Three genomics companies alone accounted for $1.335B of that total: GRAIL = $900M (Q1) Guardant Health = $360M (Q2) WuXi NextCode...
